AlphaFold predicted structure
ITGA2B · P08514

Mean pLDDT
88.1/ 100
Confident
1,039 residues
Confidence breakdown
- Very high(≥ 90)71%
- Confident(70–90)18%
- Low(50–70)3%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
integrin subunit alpha 2b
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Bleeding and platelet disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalInherited bleeding disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalCytopenia - NOT Fanconi anaemia
BIALLELIC, autosomal or pseudoautosomalCytopenias and congenital anaemias
Glanzmann thrombasthenia 1
Glanzmann thrombasthenia
autosomal dominant macrothrombocytopenia
cancer
myocardial infarction
acute coronary syndrome
Noonan syndrome
hypertrophic cardiomyopathy
Costello syndrome
Recurrent thrombophlebitis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Integrin alpha-IIb
Integrin alpha-IIb/beta-3 (ITGA2B:ITGB3) is a receptor for fibronectin, fibrinogen, plasminogen, prothrombin, thrombospondin and vitronectin. It recognizes the sequence R-G-D in a wide array of ligands. It recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in fibrinogen gamma chain (By similarity). Following activation integrin alpha-IIb/beta-3 brings about platelet/platelet interaction through binding of soluble fibrinogen (PubMed:9111081). This step leads to rapid platelet aggregation which physically plugs ruptured endothelial cell surface (By similarity). Integrin ITGA2B:ITGB3 is also the receptor of erythrocyte-specific ICAM4 ligand involved in heterotypic cell-cell adhesion between erythrocytes and activated platelets (PubMed:12477717)
ITGA2B · P08514

Mean pLDDT
88.1/ 100
Confident
1,039 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0